Login to Your Account

Washington Roundup

Wednesday, October 31, 2012
A report by the Government Accountability Office (GAO) on Part D prices, called "Discount Program Effects and Brand-Name Drug Price Trends," found that prescription costs did not go up for other people on Medicare as a result of discounts given by pharma firms to the government as a way of closing the gap in benefits for senior citizens.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription